- Home
- ZLAB vs PRVA Comparison
ZLAB vs PRVA Comparison
Compare ZLAB & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- PRVA
- Stock Information
- Founded
- ZLAB 2013
- PRVA 2007
- Country
- ZLAB China
- PRVA United States
- Employees
- ZLAB N/A
- PRVA N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- PRVA Retail: Computer Software & Peripheral Equipment
- Sector
- ZLAB Health Care
- PRVA Technology
- Exchange
- ZLAB Nasdaq
- PRVA Nasdaq
- Market Cap
- ZLAB 3.4B
- PRVA 2.8B
- IPO Year
- ZLAB 2017
- PRVA 2021
- Fundamental
- Price
- ZLAB $32.58
- PRVA $22.21
- Analyst Decision
- ZLAB Buy
- PRVA Strong Buy
- Analyst Count
- ZLAB 6
- PRVA 14
- Target Price
- ZLAB $57.22
- PRVA $28.79
- AVG Volume (30 Days)
- ZLAB 819.9K
- PRVA 682.6K
- Earning Date
- ZLAB 11-11-2025
- PRVA 11-06-2025
- Dividend Yield
- ZLAB N/A
- PRVA N/A
- EPS Growth
- ZLAB N/A
- PRVA N/A
- EPS
- ZLAB N/A
- PRVA 0.11
- Revenue
- ZLAB $427,799,000.00
- PRVA $1,900,071,000.00
- Revenue This Year
- ZLAB $42.62
- PRVA $95.64
- Revenue Next Year
- ZLAB $55.12
- PRVA $10.27
- P/E Ratio
- ZLAB N/A
- PRVA $203.12
- Revenue Growth
- ZLAB 32.56
- PRVA 12.05
- 52 Week Low
- ZLAB $20.17
- PRVA $16.47
- 52 Week High
- ZLAB $44.34
- PRVA $26.09
- Technical
- Relative Strength Index (RSI)
- ZLAB 48.51
- PRVA 51.08
- Support Level
- ZLAB $31.68
- PRVA $22.02
- Resistance Level
- ZLAB $33.06
- PRVA $22.94
- Average True Range (ATR)
- ZLAB 1.34
- PRVA 0.53
- MACD
- ZLAB 0.21
- PRVA -0.13
- Stochastic Oscillator
- ZLAB 80.97
- PRVA 32.67
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.